COMMENTARY: With biomedical research at the threshold of exciting new
discoveries, now is not the time to regulate biomedical Ph.D. producti
on on a national level, contend Howard Garrison, director of the Offic
e of Public Affairs at the Federation of American Societies for Experi
mental Biology, and Susan Gerbi, Robert P. Brown Professor of biology
and chairwoman of the department of molecular biology, cell biology, a
nd biochemistry at Brown University.